Back to results
CompletedPhase 1

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Ohio State University Medical Center

Columbus, Ohio, United States

View on ClinicalTrials.gov
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu — TrialFind